TCR2 Therapeutics (TCRR) Financial Statements
Price: $1.48
Market Cap: $58.11M
Avg Volume: 325.04K
Market Cap: $58.11M
Avg Volume: 325.04K
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of TCR2 Therapeutics.
Income Statement
| Breakdown | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 |
|---|---|---|---|---|---|---|---|
| Revenue | $- | $- | $- | $- | $- | $- | $- |
| Cost of Revenue | $- | $- | $- | $- | $- | $- | $- |
| Gross Profit | $- | $- | $- | $- | $- | $- | $- |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research and Development Expenses | $98.64M | $77.24M | $51.98M | $37.49M | $19.67M | $9.57M | $7.67M |
| General and Administrative Expenses | $24.44M | $22.50M | $16.72M | $13.89M | $6.78M | $3.61M | $2.26M |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $24.44M | $22.50M | $16.72M | $13.89M | $6.78M | $3.61M | $2.26M |
| Other Expenses | $30.42M | $- | $- | $- | $- | $- | $- |
| Operating Expenses | $123.08M | $99.74M | $68.70M | $51.38M | $26.45M | $13.18M | $9.93M |
| Cost and Expenses | $123.08M | $99.74M | $68.70M | $51.38M | $26.45M | $13.18M | $9.93M |
| Interest Income | $1.94M | $224.00K | $1.74M | $- | $- | $- | $- |
| Interest Expense | $58.90M | $- | $- | $- | $- | $- | $- |
| Depreciation and Amortization | $63.88M | $2.83M | $1.59M | $862.00K | $419.00K | $298.00K | $220.00K |
| EBITDA | $-89.62M | $-96.92M | $-67.11M | $-50.52M | $-23.83M | $-12.77M | $-9.70M |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | $-153.50M | $-99.74M | $-68.70M | $-51.38M | $-26.45M | $-13.18M | $-9.93M |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income Expenses Net | $1.94M | $224.00K | $1.74M | $3.88M | $2.20M | $110.00K | $15.00K |
| Income Before Tax | $-151.56M | $-99.52M | $-66.96M | $-47.50M | $-24.25M | $-13.07M | $-9.91M |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | $261.00K | $289.00K | $161.00K | $102.00K | $2.20M | $110.00K | $15.00K |
| Net Income | $-151.82M | $-99.81M | $-67.12M | $-47.60M | $-24.25M | $-13.07M | $-9.91M |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | $-3.93 | $-2.63 | $-2.40 | $-2.26 | $-1.05 | $-2.55 | $-1.93 |
| EPS Diluted | $-3.93 | $-2.63 | $-2.40 | $-2.26 | $-1.05 | $-2.55 | $-1.93 |
| Weighted Average Shares Outstanding | 38.63M | 37.94M | 27.99M | 21.10M | 23.19M | 5.13M | 5.13M |
| Weighted Average Shares Outstanding Diluted | 38.63M | 37.94M | 27.99M | 21.10M | 23.19M | 5.13M | 5.13M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source |
Balance Sheet
| Breakdown | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 |
|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $32.75M | $222.56M | $94.16M | $65.30M | $47.67M | $19.81M | $7.99M |
| Short Term Investments | $116.43M | $43.03M | $133.83M | $92.83M | $75.49M | $- | $8.35M |
| Cash and Short Term Investments | $149.18M | $265.59M | $227.99M | $158.12M | $123.17M | $19.81M | $16.34M |
| Net Receivables | $- | $- | $- | $- | $- | $- | $- |
| Inventory | $- | $- | $- | $- | $- | $- | $- |
| Other Current Assets | $5.16M | $10.53M | $7.55M | $5.06M | $2.33M | $892.00K | $975.00K |
| Total Current Assets | $177.62M | $276.13M | $235.54M | $163.19M | $125.49M | $20.70M | $17.32M |
| Property Plant Equipment Net | $28.68M | $45.36M | $10.01M | $4.93M | $1.64M | $1.03M | $936.00K |
| Goodwill | $- | $- | $- | $- | $- | $- | $- |
| Intangible Assets | $- | $- | $- | $- | $- | $- | $- |
| Goodwill and Intangible Assets | $- | $- | $- | $- | $- | $- | $- |
| Long Term Investments | $- | $- | $- | $- | $- | $- | $- |
| Tax Assets | $- | $- | $- | $- | $- | $- | $- |
| Other Non-Current Assets | $1.94M | $1.89M | $644.00K | $417.00K | $2.30M | $310.00K | $- |
| Total Non-Current Assets | $30.61M | $47.24M | $10.66M | $5.34M | $3.94M | $1.34M | $936.00K |
| Other Assets | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $208.24M | $323.37M | $246.19M | $168.53M | $129.43M | $22.04M | $18.25M |
| Account Payables | $2.79M | $2.14M | $2.45M | $2.48M | $2.66M | $427.00K | $508.00K |
| Short Term Debt | $50.45M | $3.37M | $- | $- | $- | $- | $- |
| Tax Payables | $- | $- | $- | $- | $- | $- | $- |
| Deferred Revenue | $- | $12.26M | $- | $- | $- | $- | $- |
| Other Current Liabilities | $10.82M | $830.00K | $6.39M | $5.05M | $2.80M | $804.00K | $458.00K |
| Total Current Liabilities | $64.06M | $18.61M | $8.84M | $7.53M | $5.46M | $1.23M | $966.00K |
| Long Term Debt | $3.32M | $23.00M | $- | $- | $- | $- | $- |
| Deferred Revenue Non-Current | $- | $- | $- | $- | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- | $- | $- |
| Other Non-Current Liabilities | $- | $293.00K | $807.00K | $546.00K | $209.66M | $47.13M | $29.17M |
| Total Non-Current Liabilities | $3.32M | $23.29M | $807.00K | $546.00K | $209.66M | $47.13M | $29.17M |
| Other Liabilities | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $67.38M | $41.89M | $9.65M | $8.08M | $215.13M | $48.36M | $30.14M |
| Preferred Stock | $- | $- | $- | $168.53M | $72.98M | $- | $- |
| Common Stock | $4.00K | $4.00K | $3.00K | $2.00K | $- | $- | $- |
| Retained Earnings | $-501.34M | $-349.52M | $-249.72M | $-182.59M | $-85.59M | $-26.32M | $-11.88M |
| Accumulated Other Comprehensive Income Loss | $-445.00K | $-13.00K | $63.00K | $142.00K | $-106.00K | $- | $-2.00K |
| Other Total Stockholders Equity | $642.64M | $631.01M | $486.20M | $174.37M | $-72.98M | $- | $- |
| Total Stockholders Equity | $140.86M | $281.48M | $236.55M | $160.45M | $-85.70M | $-26.32M | $-11.88M |
| Total Equity | $140.86M | $281.48M | $236.55M | $160.45M | $-85.70M | $- | $- |
| Total Liabilities and Stockholders Equity | $208.24M | $323.37M | $246.19M | $168.53M | $129.43M | $22.04M | $18.25M |
| Minority Interest | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $208.24M | $323.37M | $246.19M | $168.53M | $129.43M | $22.04M | $18.25M |
| Total Investments | $116.43M | $43.03M | $133.83M | $92.83M | $75.49M | $- | $8.35M |
| Total Debt | $53.76M | $26.36M | $- | $- | $- | $- | $- |
| Net Debt | $21.02M | $-196.20M | $-94.16M | $-65.30M | $-47.67M | $-19.81M | $-7.99M |
Cash Flow Statement
| Breakdown | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 |
|---|---|---|---|---|---|---|---|
| Net Income | $-151.82M | $-99.81M | $-67.12M | $-47.60M | $-24.25M | $-13.07M | $-9.91M |
| Depreciation and Amortization | $3.05M | $2.83M | $1.59M | $862.00K | $419.00K | $298.00K | $220.00K |
| Deferred Income Tax | $-293.00K | $99.00K | $131.00K | $- | $- | $- | $- |
| Stock Based Compensation | $11.38M | $12.27M | $8.49M | $6.70M | $2.13M | $408.00K | $93.00K |
| Change in Working Capital | $9.58M | $1.62M | $872.00K | $-1.10M | $3.20M | $329.00K | $222.00K |
| Accounts Receivables | $- | $- | $- | $- | $- | $- | $- |
| Inventory | $- | $- | $- | $- | $- | $- | $- |
| Accounts Payables | $1.17M | $-771.00K | $451.00K | $-179.00K | $2.22M | $-101.00K | $76.00K |
| Other Working Capital | $8.41M | $2.39M | $421.00K | $-920.00K | $975.00K | $430.00K | $146.00K |
| Other Non Cash Items | $26.65M | $1.40M | $-702.00K | $-225.00K | $-278.00K | $-1.00K | $- |
| Net Cash Provided by Operating Activities | $-101.46M | $-81.60M | $-56.74M | $-41.36M | $-18.78M | $-12.04M | $-9.38M |
| Investments in Property Plant and Equipment | $-15.45M | $-11.45M | $-7.16M | $-3.88M | $-1.02M | $-388.00K | $-869.00K |
| Acquisitions Net | $15.45M | $351.00K | $7.78M | $4.15M | $1.03M | $- | $- |
| Purchases of Investments | $-267.52M | $-50.73M | $-152.81M | $-126.26M | $-97.81M | $-6.48M | $-8.35M |
| Sales Maturities of Investments | $194.49M | $140.62M | $111.04M | $109.72M | $22.49M | $14.83M | $- |
| Other Investing Activities | $-15.45M | $-351.00K | $-7.78M | $-4.15M | $-1.03M | $-290.00K | $- |
| Net Cash Used for Investing Activities | $-88.49M | $78.45M | $-48.94M | $-20.41M | $-76.34M | $7.67M | $-9.22M |
| Debt Repayment | $- | $- | $- | $- | $- | $- | $- |
| Common Stock Issued | $256.00K | $131.33M | $133.57M | $79.13M | $125.00M | $- | $- |
| Common Stock Repurchased | $- | $- | $- | $- | $- | $- | $- |
| Dividends Paid | $- | $- | $- | $- | $- | $- | $- |
| Other Financing Activities | $125.00K | $132.14M | $134.70M | $79.52M | $122.98M | $16.18M | $22.49M |
| Net Cash Used Provided by Financing Activities | $125.00K | $132.14M | $134.70M | $79.52M | $122.98M | $16.18M | $22.49M |
| Effect of Forex Changes on Cash | $- | $- | $- | $- | $- | $- | $- |
| Net Change in Cash | $-189.82M | $128.98M | $29.02M | $17.75M | $27.86M | $11.82M | $3.89M |
| Cash at End of Period | $33.90M | $223.72M | $94.74M | $65.71M | $47.67M | $19.81M | $7.99M |
| Cash at Beginning of Period | $223.72M | $94.74M | $65.71M | $47.96M | $19.81M | $7.99M | $4.11M |
| Operating Cash Flow | $-101.46M | $-81.60M | $-56.74M | $-41.36M | $-18.78M | $-12.04M | $-9.38M |
| Capital Expenditure | $-15.45M | $-11.45M | $-7.16M | $-3.88M | $-1.02M | $-388.00K | $-869.00K |
| Free Cash Flow | $-116.91M | $-93.05M | $-63.90M | $-45.24M | $-19.80M | $-12.42M | $-10.25M |